$17.79
+0.73
(+4.28%)▲
Revenue is up for the last 2 quarters, 2.13M → 2.44M (in $), with an average increase of 12.9% per quarter
Netprofit is up for the last 2 quarters, -44.83M → -11.76M (in $), with an average increase of 281.2% per quarter
2.87%
Downside
Day's Volatility :12.19%
Upside
9.6%
70.15%
Downside
52 Weeks Volatility :75.3%
Upside
17.26%
Period | Nano-X Imaging Ltd | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 134.02% | -0.3% | -6.7% |
6 Months | 60.19% | -8.8% | -6.2% |
1 Year | 66.93% | -4.2% | -5.1% |
3 Years | -21.38% | 23.0% | 26.9% |
Market Capitalization | 965.1M |
Book Value | $3.75 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -1.82 |
Wall Street Target Price | 32.75 |
Profit Margin | 0.0% |
Operating Margin TTM | -717.66% |
Return On Assets TTM | -14.11% |
Return On Equity TTM | -42.73% |
Revenue TTM | 9.2M |
Revenue Per Share TTM | 0.17 |
Quarterly Revenue Growth YOY | 35.3% |
Gross Profit TTM | -6.9M |
EBITDA | -54.6M |
Diluted Eps TTM | -1.82 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.04 |
EPS Estimate Next Year | -0.51 |
EPS Estimate Current Quarter | -0.34 |
EPS Estimate Next Quarter | -0.32 |
What analysts predicted
Upside of 84.09%
Sell
Neutral
Buy
Nano-X Imaging Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Nano-X Imaging Ltd | 65.79% | 60.19% | 66.93% | -21.38% | -21.38% |
![]() Stryker Corporation | -9.47% | 16.08% | 15.77% | 37.64% | 56.01% |
![]() Boston Scientific Corp. | -4.37% | 11.53% | 23.12% | 34.64% | 66.14% |
![]() Edwards Lifesciences Corp. | -7.01% | 5.39% | -19.28% | 9.61% | 77.87% |
![]() Abbott Laboratories | -8.46% | -5.46% | -13.41% | 9.35% | 65.3% |
![]() Medtronic PLC | -9.02% | 4.38% | -17.62% | -15.04% | -4.43% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Nano-X Imaging Ltd | NA | NA | NA | -1.04 | -0.43 | -0.14 | 0.0 | 3.75 |
![]() Stryker Corporation | 39.68 | 39.68 | 2.85 | 10.16 | 0.16 | 0.06 | 0.01 | 44.51 |
![]() Boston Scientific Corp. | 88.03 | 88.03 | 2.53 | 1.95 | 0.05 | 0.04 | 0.0 | 12.42 |
![]() Edwards Lifesciences Corp. | 33.89 | 33.89 | 3.07 | 2.55 | 0.25 | 0.13 | 0.0 | 9.87 |
![]() Abbott Laboratories | 31.27 | 31.27 | 18.76 | 4.4 | 0.16 | 0.06 | 0.02 | 21.28 |
![]() Medtronic PLC | 28.89 | 28.89 | 3.04 | 5.28 | 0.07 | 0.04 | 0.03 | 38.69 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Nano-X Imaging Ltd | Buy | $965.1M | -21.38% | NA | 0.0% |
![]() Stryker Corporation | Buy | $103.5B | 56.01% | 39.68 | 13.86% |
![]() Boston Scientific Corp. | Buy | $73.4B | 66.14% | 88.03 | 6.92% |
![]() Edwards Lifesciences Corp. | Buy | $49.7B | 77.87% | 33.89 | 27.07% |
![]() Abbott Laboratories | Buy | $178.9B | 65.3% | 31.27 | 13.98% |
![]() Medtronic PLC | Buy | $108.4B | -4.43% | 28.89 | 12.03% |
BlackRock Inc
State Street Corporation
Credit Suisse First Boston (CSFB)
Geode Capital Management, LLC
Morgan Stanley - Brokerage Accounts
VK Services LLC
Nano-X Imaging Ltd’s price-to-earnings ratio stands at None
Read MoreNano-X Imaging Ltd operates as a medical imaging technology company. The Company offers cloud-based image analysis, online diagnosis, and billing services. Nano-X Imaging serves governments, hospitals, and clinic chains in Israel.
Organization | Nano-X Imaging Ltd |
Employees | 180 |
CEO | Mr. Ran Poliakine |
Industry | Health Technology |
WisdomTree US AI Enhanced Value Fund
$87.78
-0.41%
HOOKIPA Pharma Inc.
$1.31
-5.76%
BLACKROCK MUNIYIELD QUAL II
$9.91
-0.2%
LUTHER BURBANK CORP
$8.60
-2.49%
Market Vectors Biotech ETF
$154.74
-0.08%
NOW Inc.
$8.89
-4.1%
Central Garden & Pet Co A Shares
$34.35
-0.95%
FARMERS & MERCHANTS BANCO/OH
$19.89
-2.98%
ISHARES GOLD TRUST MICRO
$19.61
+0.18%